- Home
- LITE vs MRNA Comparison
LITE vs MRNA Comparison
Compare LITE & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LITE | MRNA |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.1B | 21.5B |
| IPO Year | 2015 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LITE | MRNA |
|---|---|---|
| Price | $952.51 | $45.33 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 12 |
| Target Price | ★ $645.43 | $34.27 |
| AVG Volume (30 Days) | ★ 5.0M | 4.9M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.56 | 21.77 |
| EPS | ★ 0.99 | N/A |
| Revenue | $1,247,700,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | $79.88 | $9.36 |
| Revenue Next Year | $66.61 | $15.43 |
| P/E Ratio | $914.51 | ★ N/A |
| Revenue Growth | ★ 24.57 | 4.29 |
| 52 Week Low | $60.38 | $22.28 |
| 52 Week High | $960.00 | $59.55 |
Technical Indicators
Market Signals| Indicator | LITE | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 62.07 | 34.62 |
| Support Level | $159.28 | $23.52 |
| Resistance Level | N/A | $55.36 |
| Average True Range (ATR) | 64.53 | 2.87 |
| MACD | -1.94 | -1.00 |
| Stochastic Oscillator | 84.06 | 13.14 |
Price Performance
Historical ComparisonAbout LITE Lumentum Holdings Inc.
Lumentum Holdings Inc is a California-based technology firm. The company provides two types of optical and photonic products: optical components that are used in telecommunications networking equipment, and commercial lasers for manufacturing, inspection, and life-science lab uses. Its segments are Optical Communications and Commercial Lasers. The firm is also expanding into new optical applications, such as 3-D sensing laser diode for consumer electronics. It generates maximum revenue from the OpComms segment. The OpComms segment products include a wide range of components, modules, and subsystems to support customers including carrier networks for access (local), metro (intracity), long-haul, and submarine (undersea) applications.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.